Month: October 2020
-
Heart Disease Biotech Acquired in $13.1B Deal
A company developing precision medicine drugs to treat inherited heart disorders was acquired by drug maker Bristol Myers Squibb, or BMS, for $13.1 billion.
-
BARDA Funding Vaccine Patch Clinical Trial
The U.S. government’s medical preparedness agency is funding a clinical trial of a patch that dispenses vaccines with a much lower dose than syringes.
-
Infographic – Global Climate Technology Hubs
The report also highlights where the investments were made, with the geographic hubs or clusters attracting the most investments, this weekend’s infographic.
-
Int’l Lab Network to Assess Covid-19 Vaccines
Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols.
-
Wireless Sensor Detects Multiple Covid-19 Indicators
Biomedical engineers designed a lab-on-a-chip sensor that quickly detects SARS-CoV-2 viruses in saliva or blood, as well as antibodies and indicators of disease severity.
-
Biotech, Analytics Companies Partner on Drug Discovery
A biotechnology company and genomics data science enterprise agreed in a multi-year agreement to discover new therapies for up to 20 diseases.
-
Group Advancing Electronic Spinal Cord Injury Therapies
A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries.